IHM
AXDX

Iguana Healthcare Management’s Accelerate Diagnostics AXDX Stock Holding History

Iguana Healthcare Management’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,500
Closed -$359K – 84
2016
Q1 		$359K Buy
+2,500
New +$353K 0.13% 74

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
MGM
Miura Global Management New York $25.2M AUM 60.6% 1-Year Est. Return

Iguana Healthcare Management's AXDX Position: Q1 2017 in Review

Iguana Healthcare Management sold out of Accelerate Diagnostics (AXDX) in Q1 2017, closing a stake of 3,000 shares — an estimated $623K sold.

Iguana Healthcare Management first reported a position in AXDX in Q4 2013 and held it in 10 quarters. The position peaked at $6.97M in Q2 2015. 98 funds tracked by Wall St. Rank hold AXDX as of Q1 2017.

  • Iguana Healthcare Management reported no remaining Accelerate Diagnostics position as of Q1 2017 after selling out during the quarter.
  • Iguana Healthcare Management sold 3,000 Accelerate Diagnostics shares in Q1 2017, an estimated $623K.
  • Iguana Healthcare Management first reported a position in Accelerate Diagnostics in Q4 2013 and held it in 10 quarters.
  • Iguana Healthcare Management's Accelerate Diagnostics position peaked at $6.97M in Q2 2015.
  • 98 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2017.

Based on Iguana Healthcare Management's 13F filing for Q1 2017, filed 15 May 2017.